Dr. S.0 MIKAYE/LinkedIn
Dec 23, 2025, 08:57
Samwel Mikaye Explains PNH: Cause, Key Clinical Features, Investigations and More
Samwel Mikaye, CEO of SaMik Medical Center, posted on LinkedIn:
“Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare acquired hematologic disorder characterized by intravascular hemolysis, bone marrow failure, and thrombosis.
Cause / Pathophysiology
- Caused by a somatic mutation in the PIGA gene
- Leads to deficiency of GPI-anchored proteins on blood cells
- Key missing protective proteins:
- CD55 (DAF)
- CD59
- Without these, red blood cells are destroyed by complement
Key clinical features
- Hemoglobinuria, often noticed in the morning
- Anemia (fatigue, pallor)
- Jaundice
- Abdominal pain
- Dysphagia
- Erectile dysfunction
- Venous thrombosis (unusual sites: hepatic, portal, cerebral veins)
- May be associated with aplastic anemia
Investigations
- Flow cytometry: absence or reduction of CD55 and CD59 (diagnostic test)
- Low hemoglobin
- Raised LDH
- Low haptoglobin
- Negative Coombs test
- Possible pancytopenia
Management
- Eculizumab or Ravulizumab (complement inhibitors)
- Folic acid supplementation
- Blood transfusions if needed
- Anticoagulation for thrombosis
- Bone marrow transplant in severe cases
Complications
- Life-threatening thrombosis
- Chronic kidney disease
- Progression to aplastic anemia or acute leukemia
- Acquired (not inherited)
- Intravascular hemolysis
- Negative direct Coombs test
- Flow cytometry is diagnostic”
Develop hematology knowledge with Samwel Mikaye’s posts.
-
Jul 4, 2026, 17:38Michael Stark: Greater Improvements in Cerebral Oxygenation With Restrictive Transfusion Thresholds
-
Jul 4, 2026, 17:27Reza Shojaei: How America Won the Plasma Race
-
Jul 4, 2026, 17:26Akshat Jain: The First CRISPR-Cas9 Gene Therapy Approved for Children as Young as 2 with SCD
-
Jul 4, 2026, 17:25Francesca Palandri: Dynamic, Treatment Response-Driven Risk Assessment in Polycythemia Vera
-
Jul 4, 2026, 17:24Thierry Burnouf: The Fragile Supply of Human Hyperimmune Immunoglobulins
-
Jul 4, 2026, 15:41Emmanuel J. Favaloro: New Research Highlights Benchmarks for Low Molecular Weight Heparin Monitoring
-
Jul 4, 2026, 15:38Roshni Kulkarni: Maternal Mortality In Bleeding Disorders
-
Jul 4, 2026, 15:34Alejandro González Veliz: Does Elevated Lp(a) Always Mean the Same Cardiovascular Risk?
-
Jul 4, 2026, 15:20Bruno Pougault: Heparin Monitoring Remains One of the Most Challenging Areas in Laboratory Hemostasis